Long-term follow-up of cervical dystonia patients treated with botulinum toxin A. - Wikidata - wikimedia - TriplyDB

Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.

Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.

http://www.wikidata.org/entity/Q34305982

about

British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin The non-motor syndrome of primary dystonia: clinical and pathophysiological implications [Botulinum toxin therapy for spasmodic torticollis: medical and non-medical adjunct treatment].Current and future medical treatment in primary dystonia.The safety and tolerability of botulinum toxins for the treatment of cervical dystonia.Botulinum toxin therapy for cervical dystonia: the science of dosing A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins Clinical value of botulinum toxin in neurological indications.Safety and efficacy of botulinum toxin type A following long-term use.The management of cervical dystonia.Long-term efficacy and safety of botulinum toxin injections in dystonia.Survey of practices employed by neurologists for the definition and management of secondary non-response to botulinum toxin in cervical dystonia.Botulinum toxin type A in the treatment of patients with cervical dystonia Clinical Characteristics and Response to Long-Term Botulinum Toxin Type A Therapy in Patients with Cervical Dystonia at a Neurology Clinic.Botulinum toxin A (Dysport®): in dystonias and focal spasticity.Efficacy and safety of long-term botulinum toxin treatment in craniocervical dystonia: a systematic review.Immunogenicity of botulinum toxins.A long-term follow-up of botulinum toxin A in cervical dystonia.Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?[Modern non-cosmetic treatment with botulinum toxins].Good long-term efficacy of pallidal stimulation in cervical dystonia: a prospective, observer-blinded study.Long-Term Abobotulinumtoxin A Treatment of Cervical Dystonia.Botulinum Toxin Induced Atrophy: An Uncharted Territory

P2860

Q26765776-52D8AD64-A3CE-4E99-9F85-D75158874D81 Q27012793-F2766D8B-CA0C-49E5-8582-31C14B8F0481 Q30317891-55BE315A-C092-49BE-951E-F3F28B64647F Q30465848-1722DFBF-AA31-4B93-8EBC-46CCE98D139D Q34406870-2C8D3F4B-02C2-4CC4-823D-4DCBA20CF0D2 Q34518731-8ACF06E9-E0C2-426B-9778-E9476DCA2F27 Q35681898-24A46361-5894-4D76-9C25-8A1AE3D47EF9 Q36656469-58B571F7-58F1-4D72-A38D-B445ED6511B3 Q36656478-FA1BA26D-320B-4CD1-9744-532CC19465D3 Q36719664-30FD8376-06FD-42CF-AF7A-2A367C638F1E Q36807185-5427F1DC-9D2F-46CB-B7DE-8F139935797F Q37388338-C8FDF33B-78A6-43D0-96CF-84613D95DB73 Q37586904-9D5DCD0E-9EFB-46B6-87C0-0C6C4EE3D431 Q37704010-E419581A-9219-4383-AF2D-23AF33DF93D2 Q37888668-57FAAE58-9852-484C-AA05-F00AEF8FC6BB Q37987484-70B7289E-8EF9-4212-975C-A2EAF83AFB9F Q38046142-DC176144-DB93-45FF-A772-C6E9D03BA3B3 Q44590149-D37FB286-955E-48D3-8D9C-19E78784DEE8 Q48008185-1212293C-B4BF-40C1-801B-EBE11771A238 Q48556994-9E22EAB1-6D0E-4265-AF0F-0470D46591B0 Q48799571-F31A7C73-70D3-4F5D-BF2A-E62824FCD790 Q50668003-605DA3BA-A864-4EE7-ABC6-ED7DC08B0CDC Q57171247-F89E7FD0-A8E0-4425-9CE2-445142BBE91C

P2860

Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.

http://www.wikidata.org/entity/Q34305982

description

2004 nî lūn-bûn

@nan

2004 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի մարտին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.

@ast

Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.

@en

Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.

@nl

type

label

Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.

@ast

Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.

@en

Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.

@nl

prefLabel

Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.

@ast

Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.

@en

Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.

@nl

P1433

Q34305982-7C7D3C9A-8E5C-4746-BD98-4F2BEC00FDFF

P1476

Q34305982-894F8A54-6105-45E4-9F0E-EB097E666E74

P2093

Q34305982-56551AFB-D5CE-40CF-8615-9CFF7DB14643

Q34305982-6E55313E-F6C7-460D-82E2-D0693016FB30

Q34305982-71092F65-96E4-407E-800D-AF6D54E7CC27

Q34305982-C67F6C7D-63DD-4EFC-B05B-8A9AFBC8967A

Q34305982-D98F517A-584B-4788-9557-D095D63974F1

Q34305982-E8CCC3C3-6D99-4DC7-9096-BC12E501918B

P2860

Q34305982-1754DFBD-0C6E-4AF6-BC87-6465581D4F12

Q34305982-1EE1C420-429B-4139-A80F-440BF4D5618A

Q34305982-7A54F854-FA68-4D7D-B3FA-36B9E1C28F63

Q34305982-A291C14F-5884-4BE6-9C97-56712A71DD5E

Q34305982-B7990FEA-2527-437B-8391-81D56A041CF4

P304

Q34305982-C6154857-519E-4032-9845-C3CA03196A61

P31

Q34305982-4243644E-1682-44E1-92F3-3D6342860F76

P356

Q34305982-5CEE0EE8-1BD4-4B5F-8C54-2F6C83DC93CB

P407

Q34305982-DDAB6A51-DA2B-410E-8C25-01C104C89A4E

P433

Q34305982-80E9F610-2D97-4264-B2DE-5BBCC571EE5E

P478

Q34305982-0EEC94F9-C006-464E-8DB7-1C23D4BD2296

P50

Q34305982-D9A069F0-762D-400C-B71F-3A16E47707D5

P577

Q34305982-5863F147-A9FF-4E0C-AD6B-25C96A4439E7

P698

Q34305982-4EF87E6B-A4C8-444C-94EC-873414EB5B1C

P356

P1433

Movement Disorders

P1476

Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.

@en

P2093

Andres Ceballos-Baumann

http://www.w3.org/2001/XMLSchema#string

Bastian Conrad

http://www.w3.org/2001/XMLSchema#string

Christiane Klinger

http://www.w3.org/2001/XMLSchema#string

Michael Landgrebe

http://www.w3.org/2001/XMLSchema#string

Peter Haussermann

http://www.w3.org/2001/XMLSchema#string

Stefanie Marczoch

http://www.w3.org/2001/XMLSchema#string

P2860

The clinical course of spasmodic torticollis.

Cervical dystonia: clinical findings and associated movement disorders.

Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study.

Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis.

Long-term effect of botulinum toxin on impairment and functional health in cervical dystonia.

P304

303-308

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.10659

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Andres Ceballos-Baumann

P577

2004-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15022184

http://www.w3.org/2001/XMLSchema#string